New markers to better diagnose colorectal cancer referrals
Part of Cancer, Digestive system clinical trials.
This study looks for new markers in the blood or stool to help diagnose colorectal cancer earlier. It is for people who have been referred urgently because their doctor suspects lower bowel cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You were referred urgently (2-week wait) or for a direct test for suspected lower bowel cancer
- You do not have a history of inflammatory bowel disease (like Crohn's or ulcerative colitis)
- You are well enough to have standard tests like a colonoscopy or CT scan
- You can understand and agree to take part in the study
- You do not have any other active, untreated solid organ cancers or a known inherited bowel cancer syndrome
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to find colorectal cancer early. You may be able to join if you are about to have a colonoscopy or surgery for a suspected tumor.
This study is evaluating PreveCol, a new second-line stool test for people aged 50–69 who had a positive FIT/FOBT result and are already scheduled for a colonoscopy. It aims to find out if this test can help detect colorectal cancer earlier.
This study tests a new device that helps doctors see polyps during a colonoscopy. It may help find more polyps early, which could prevent cancer.
This study is looking at whether routine lab tests can help find colorectal adenomas (non-cancerous polyps in the colon) earlier. If you are having a colonoscopy and are found to have such a polyp, you may join to help improve early detection.
This trial tests a new stool-based screening test that may find colorectal cancer and advanced adenomas (precancerous growths) early. It studies whether the test works well compared with the standard colonoscopy, so it could offer an easier, less invasive screening option in the future.
This study is looking for people newly diagnosed with colorectal cancer or advanced adenoma to help find better ways to detect the disease early using advanced lab tests on blood samples.
Hear when a new Colorectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.